Dittrich, Tolga D.
Vock, Dominik
Fisch, Urs
Hert, Lisa
Baumann, Sira M.
Kliem, Paulina S.C.
Rüegg, Stephan
Marsch, Stephan
De Marchis, Gian Marco
Sutter, Raoul http://orcid.org/0000-0002-6575-356X
Funding for this research was provided by:
University of Basel
Article History
Received: 11 October 2023
Accepted: 27 February 2024
First Online: 5 April 2024
Conflict of interest
: TDD was or is supported by the Swiss Heart Foundation, the science funds of the University Hospital Basel, and the research fund for excellent young researchers of the University of Basel. He holds shares from Johnson&Johnson, Roche, Lilly, Bristol-Myers Squibb, Merck, and Novo Nordisk. RS received research grants from the Swiss National Foundation (No 320030_169379), the Research Fund of the University Basel, the Scientific Society Basel, and the Bangerter-Rhyner Foundation. He received personal grants from UCB pharma and holds stocks from Novartis, Roche, Alcon, and Johnson&Johnson. The remaining authors report no conflicts of interest relevant to this review.
: Ethics committee approval was not required for this systematic review.
: CRD42022369040 (PROSPERO study ID).